Xponance’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.34M | Sell |
10,688
-3,624
| -25% | -$793K | 0.02% | 502 |
|
2025
Q1 | $3.2M | Sell |
14,312
-390
| -3% | -$87.3K | 0.03% | 404 |
|
2024
Q4 | $4.82M | Sell |
14,702
-2,056
| -12% | -$673K | 0.04% | 313 |
|
2024
Q3 | $5.03M | Buy |
16,758
+2,667
| +19% | +$801K | 0.05% | 304 |
|
2024
Q2 | $4.64M | Sell |
14,091
-2,962
| -17% | -$976K | 0.05% | 301 |
|
2024
Q1 | $6.75M | Buy |
17,053
+483
| +3% | +$191K | 0.07% | 231 |
|
2023
Q4 | $5.83M | Sell |
16,570
-829
| -5% | -$292K | 0.07% | 230 |
|
2023
Q3 | $6.53M | Buy |
17,399
+297
| +2% | +$111K | 0.09% | 189 |
|
2023
Q2 | $6.54M | Buy |
17,102
+204
| +1% | +$78K | 0.09% | 197 |
|
2023
Q1 | $5.85M | Sell |
16,898
-373
| -2% | -$129K | 0.09% | 222 |
|
2022
Q4 | $4.06M | Buy |
17,271
+2,248
| +15% | +$529K | 0.07% | 275 |
|
2022
Q3 | $3.7M | Buy |
15,023
+1,049
| +8% | +$258K | 0.07% | 253 |
|
2022
Q2 | $4.23M | Buy |
13,974
+1,300
| +10% | +$393K | 0.08% | 199 |
|
2022
Q1 | $5.21M | Sell |
12,674
-7,725
| -38% | -$3.17M | 0.09% | 191 |
|
2021
Q4 | $9.57M | Sell |
20,399
-7,113
| -26% | -$3.34M | 0.15% | 118 |
|
2021
Q3 | $11.7M | Sell |
27,512
-419
| -2% | -$178K | 0.22% | 81 |
|
2021
Q2 | $10M | Buy |
27,931
+17,122
| +158% | +$6.15M | 0.18% | 97 |
|
2021
Q1 | $3.05M | Buy |
10,809
+2
| +0% | +$564 | 0.06% | 239 |
|
2020
Q4 | $3.06M | Buy |
10,807
+207
| +2% | +$58.7K | 0.07% | 239 |
|
2020
Q3 | $2.91M | Sell |
10,600
-36
| -0.3% | -$9.9K | 0.07% | 219 |
|
2020
Q2 | $2.42M | Buy |
+10,636
| New | +$2.42M | 0.06% | 237 |
|